Skip to main content
Clinical Trials/NCT03612583
NCT03612583
Completed
Phase 1

Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work

University Health Network, Toronto1 site in 1 country23 target enrollmentFebruary 1, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Diaphragm Injury
Sponsor
University Health Network, Toronto
Enrollment
23
Locations
1
Primary Endpoint
Rate of patients achieving and maintaining LDPV targets
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study is designed to test a proposed strategy for lung- and diaphragm-protective ventilation (LDPV) in patients with acute hypoxemic respiratory failure. Ventilation and sedation will be titrated to evaluate whether it is feasible and safe within this patient population.

Detailed Description

Lung injury and diaphragm injury incurred by mechanical ventilation have very serious adverse effects on patients with acute respiratory failure. Lung injury results from excessive mechanical stress and strain applied to the lung by the ventilator and/or respiratory muscles, while diaphragm injury results from either insufficient or excessive inspiratory effort. The objective of this study is to investigate a new LDPV strategy designed to prevent both disuse-mediated and load-induced diaphragm injury, while also preventing excess global and regional mechanical stress and strain in the injured lung. To achieve these goals, the following specific targets to be met are: (1) respiratory muscle effort similar to that of healthy subjects breathing at rest, (2) lung stress within safe limits, and (3) clinically acceptable gas exchange. Targets are assessed through measurements of global lung stress, tidal recruitment, inspiratory effort, diaphragm contractile effort and adequacy of respiratory muscle and systemic tissue perfusion. Measurements commence at enrollment and continue for 24 hours consecutively.

Registry
clinicaltrials.gov
Start Date
February 1, 2019
End Date
November 30, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with acute hypoxemic respiratory failure
  • PaO2:FiO2 ratio less than or equal to 300 mm Hg at time of screening
  • Oral endotracheal intubation and mechanical ventilation
  • Bilateral airspace opacities on chest radiograph or chest CT scan

Exclusion Criteria

  • Liberation from mechanical ventilation is anticipated within 24 hours
  • Intubated for traumatic brain injury or stroke
  • Contraindication to esophageal catheterization
  • Intracranial hypertension

Outcomes

Primary Outcomes

Rate of patients achieving and maintaining LDPV targets

Time Frame: Assessed after achievement of LDPV targets for 24 hours

Secondary Outcomes

  • Expiratory diaphragmatic effort at lower and higher PEEP levels(Assessed 10 minutes after PEEP and sedation are adjusted)
  • Inspiratory effort at low and high sweep gas flow rates(Assessed 10 minutes after PEEP and sedation are adjusted)
  • Sedative infusion rate at low and high sweep gas flow rates(Assessed 10 minutes after PEEP and sedation are adjusted)
  • Inspiratory effort at lower and higher PEEP levels(Assessed 10 minutes after PEEP and sedation are adjusted)
  • Lung stress and strain at low and high sweep gas flow rates(Assessed 10 minutes after PEEP and sedation are adjusted)
  • Accuracy of artificial intelligence model in predicting patient outcomes(Assessed after completing the 24-hour maintenance period)

Study Sites (1)

Loading locations...

Similar Trials